Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Value Fund median (23 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 01 Dec 2021 – 20 Aug 2026, limited by Quant Value Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Quant Value Fund | Nifty 500 |
|---|---|---|
| 01 Dec 2021 | ₹100.00 | ₹100.00 |
| 24 Apr 2022 | ₹109.54 | ₹100.75 |
| 14 Sep 2022 | ₹112.89 | ₹105.72 |
| 05 Feb 2023 | ₹112.23 | ₹101.20 |
| 28 Jun 2023 | ₹123.78 | ₹110.09 |
| 19 Nov 2023 | ₹142.60 | ₹119.05 |
| 11 Apr 2024 | ₹203.39 | ₹141.47 |
| 01 Sep 2024 | ₹228.47 | ₹160.53 |
| 23 Jan 2025 | ₹197.88 | ₹145.68 |
| 15 Jun 2025 | ₹202.93 | ₹154.93 |
| 06 Nov 2025 | ₹208.24 | ₹159.04 |
| 29 Mar 2026 | ₹195.30 | ₹142.18 |
| 20 Aug 2026 | ₹239.14 | ₹159.04 |
| Metric | quant · Direct NAV ₹24.02 Very High risk ★★★★☆ | Category median Value Fund · 23 funds |
|---|---|---|
| +17.06% | +3.57% | |
| +22.13% | +15.04% | |
| — | +14.76% | |
| — | +14.36% | |
| +20.30% | +16.07% | |
| +19.90% | — | |
| +24.26% | +18.30% | |
| — | +15.85% | |
| — | +15.98% | |
| Risk | ||
| 18.82% | 14.38% | |
| 0.83 | 0.58 | |
| 1.13 | 0.80 | |
| -24.03% | -36.70% | |
| Nifty 500 | — | |
| +8.72% | +2.91% | |
| 1.22 | 0.96 | |
| 137.3% | 103.3% | |
| 103.2% | 93.3% | |
| 0.92% | 1.14% | |
| ₹1,784Cr | ₹1,662Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| — | 36% | |
| Sanjeev Sharma | — | |
| 01 Dec 2021 | — | |
| 24 | — | |
| 61.1% | — | |
| 9.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.